Bcl-xL activity influences outcome of the mitotic arrest
Microtubule-targeting (MT) drugs taxanes and vinca alkaloids are widely used as chemotherapeutic agents against different tumors for more than 30 years because of their ability to block mitotic progression by disrupting the mitotic spindle and activating the spindle assembly checkpoint (SAC) for a p...
Saved in:
Main Authors: | M. Suleimenov (Author), S. Bekbayev (Author), M. Ten (Author), N. Suleimenova (Author), M. Tlegenova (Author), A. Nurmagambetova (Author), S. Kauanova (Author), I. Vorobjev (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Cytoskeleton in the focus of anti-cancer therapy: In a search of novel biomarkers and combinatorial therapy approaches
by: I. Vorobjev, et al.
Published: (2022) -
BCL-xL is correlated with disease severity in neonatal infants with early sepsis
by: Wu Wenshen, et al.
Published: (2021) -
MDM2-BCL-XL PROTACs enable degradation of BCL-XL and stabilization of p53
by: Mengyang Chang, et al.
Published: (2022) -
Bcl-xL DNAzymes promote radiosensitivity and chemosensitivity in colorectal cancer cells via enhancing apoptosis
by: Zhen Yu, et al.
Published: (2022) -
Doxorubicin Changes Bax /Bcl-xL Ratio, Caspase-8 and 9 in Breast Cancer Cells
by: Simin Sharifi, et al.
Published: (2015)